Resonant Therapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Resonant Therapeutics, Inc.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The Asthma Challenge: Not Solved Yet, features profiles of airPharma, Aperon Biosystems, Inverseon and Topigen Pharmaceuticals. Plus these Start-Ups across Health Care: Ensemble Discovery, Miikana Therapeutics, MiTiHeart and Resonant Medical.
Resonant Medical has 510(k) approval for a multilevel platform for electronically collecting 3-D CT and ultrasound images from cancer patients in their planning and treatment stages.
- Drug Discovery Tools
Drug Discovery Tools
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.